Hepatobiliary Surgery and Nutrition

Papers
(The TQCC of Hepatobiliary Surgery and Nutrition is 2. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-08-01 to 2025-08-01.)
ArticleCitations
Surgical treatment of colorectal cancer liver metastases: individualized comprehensive treatment makes a difference128
Neoadjuvant therapy for resectable pancreatic cancers94
Preoperative assessment of liver function and perioperative management of posthepatectomy liver failure75
Review of practice informing data and current state of NCCN consensus guidelines in hepatobiliary cancers70
Surgical decision-making: can patients benefit?62
Reply to: The letter to the editor “More details are needed about the use of multicenter propensity score matching analysis” by Feng et al.43
Acute coil migration in upper gastrointestinal bleeding39
Heterogeneity in the risk of incident liver cirrhosis driven by PNPLA3 genotype and diabetes among different populations39
Does a patient who needs portal vein embolization (PVE) to proceed to major hepatectomy (MH) have the same hepatic functional reserve than a patient with no preoperative PVE?33
Futibatinib: new targeted therapy in intrahepatic cholangiocarcinoma31
Can we talk about “futile surgery” for the upfront treatment of the perihilar cholangiocarcinoma?31
Managing portal hypertension in patients with liver cirrhosis and hepatocellular carcinoma: non-invasive diagnosis and systemic treatment considerations27
Short postoperative hospital stay after pancreaticoduodenectomy: what is real minimally invasive surgery?26
The application of real-time indocyanine green fluorescence cholangiography in laparoscopic living donor left lateral sectionectomy23
Simultaneous resection of synchronous colorectal liver metastases: a promising alternative to staged resections23
Loco-regional treatments of unresectable hepatocellular carcinoma: safety first22
Prospective evaluation of 18F-FDG positron emission tomography in the preoperative staging of patients with hepatic colorectal metastases21
Enhanced recovery for liver transplantation: recommendations from the 2022 International Liver Transplantation Society Consensus Conference: towards better clinical care in transplant hepatology20
Technical performance, surgical workload and patient outcomes of robotic and laparoscopic surgery for pediatric choledochal cyst: a multicenter retrospective cohort and propensity score-matched study20
Assessment of long-term graft function following total pancreatectomy and autologous islet transplantation: the Leicester experience20
Nonalcoholic steatohepatitis critically rewires the ischemia/reperfusion-induced dysregulation of cardiolipins and sphingolipids in mice20
Liver transplantation for hepatocellular carcinoma arising in non- cirrhotic liver: a national-wide retrospective cohort study with propensity score matching analysis in China19
A 7-year-old girl with giant congenital biliary dilatation19
Reply to the commentary on “The efficiency of pathological response after preoperative transcatheter arterial chemoembolization for microvascular invasion and early tumor recurrence in hepatocellular 18
The Society for Immunotherapy of Cancer clinical practice guideline on immunotherapy for hepatocellular carcinoma18
Comment on: “Liver transplantation for iatrogenic bile duct injury during cholecystectomy: a French retrospective multicenter study”17
Guidelines for the management of pancreatic cystic lesions: many options, too few solutions?17
Innovations in liver organoids: the role of 3D bioprinting in creating functional organoids17
Enhancing diagnostic strategies for biliary strictures: an evolving landscape15
Robotic hepatectomy: challenge and progression15
Semaglutide for nonalcoholic steatohepatitis: closer to a solution?15
Comment on “Perihilar cholangiocarcinoma—novel benchmark values for surgical and oncological outcomes from 24 expert centers”15
Performance of major liver resection for gallbladder cancer—a western retrospective single center cohort study14
Dietitians’ role in obesity care: insights from the Academy of Nutrition and Dietetics13
Extracellular vesicles small RNA clusters: hit the nail on the head of liver cancer detection13
Evolocumab induced short-term biliary stent blockage and acute cholangitis in a jaundice patient with pancreatic carcinoma: a rare complication of PCSK9 inhibitor13
Propensity score matching study of 325 patients with spontaneous rupture of hepatocellular carcinoma12
A novel radiomics signature based on T2-weighted imaging accurately predicts hepatic inflammation in individuals with biopsy-proven nonalcoholic fatty liver disease: a derivation and independent valid12
Construction and application of multicellular tumor microenvironment models based on three-dimensional bioprinting technology12
Addressing the malnutrition gap requires high-quality research, recognition of intervention complexity, and equitable implementation strategies12
Body fat distribution: a crucial target for intervention in nonalcoholic fatty liver disease and fibrosis11
Perioperative management of patients with liver cancer complicated with sarcopenia11
Safety analysis of COVID-19 vaccines in liver transplant recipients: a two-center study11
“One-day, one-stay, and one-step” lessons from the Danish guidelines for the treatment of gallstone disease11
Expert consensus on difficult airway assessment11
Novel biomarkers for hepatocellular carcinoma detection and treatment11
Editorial comment on: development and external validation of a model to predict overall survival in patients with resected gallbladder cancer11
The 11th revision of the International Statistical Classification of Disease and Related Health Problems and Cholangiocarcinoma11
Impact of donor-recipient sex-matching patterns on liver transplantation outcomes: a cohort study based on United Network of Organ Sharing data10
Laparoscopic partial splenectomy in the treatment of splenic ectopic pregnancy10
Understanding drug-induced liver injury from the perspective of traditional Chinese medicine theory—Huohou theory of traditional Chinese medicine10
Optimizing strategies to reduce alcohol consumption and relapses, improving abstinence in liver transplant recipients10
Spontaneous regression of solid-pseudopapillary neoplasms with hepatic metastases9
Combination therapies for advanced hepatocellular carcinoma: a beacon of light or a castle in the air9
Association of a novel glycemic control index, time in range, with infectious complications after pancreatectomy9
Thermal ablation in the curative treatment of colorectal liver metastasis: new standard of care?—lessons learned from the COLLISION trial9
Practice guidance documents for the diagnosis and management of non-alcoholic fatty liver disease—recent updates and open questions8
Optimization of immunotherapy for patients with hepatobiliary cancer8
How to improve the care of decompensated cirrhosis: the intervention model for chronic disease management8
Highlights of constructing liver-relevant in vitro models with 3D bioprinting8
Trimming the fat myth: adipose tissue’s role in liver regeneration8
Rules: abide or abandon?8
Construction of an intrahepatic portosystemic shunt using the magnetic compression technique: preliminary experiments in a canine model8
Liver resection versus liver transplantation for hepatocellular carcinoma within Milan criteria: a meta-analysis of 18,421 patients8
Robotic-assisted hepatopancreatoduodenectomy and resection of pancreatic tail for one multiple endocrine neoplasia type 1 secreting multiple hormones8
Sengstaken-Blakemore tubes: a rescue system during liver transplantation7
Difficulties and opportunities of hospice care—the role of doctors7
“Winning” with laparoscopic liver resection for colorectal cancer liver metastases (CRLM)7
Targeted therapies in cholangiocarcinoma: light at the end of the tunnel?7
Liver transplantation for perihilar cholangiocarcinoma is not a provocative idea7
Prediction of postoperative early recurrence and response to adjuvant transcatheter arterial chemoembolization in hepatocellular carcinoma with microvascular invasion after hepatectomy: a multicenter 7
Minimally invasive hepatectomy is here to stay, but more evidence is needed7
Confounders in developing a machine learning model for colorectal liver metastasis post-hepatectomy prognostications7
ALPPS versus portal vein embolization for hepatitis B virus-associated hepatocellular carcinoma: a delicate balance between volume and morbidity7
Metabolic (dysfunction) associated fatty liver disease: more evidence and a bright future6
Evolution of systemic therapy for advanced-stage hepatocellular carcinoma6
Novel preoperative strategies to improve hepatocellular carcinoma resectability6
Algorithm-based care for early recognition and management of complications after pancreatic resection: toward standardization of postoperative care6
Accuracy of non-invasive liver stiffness measurement and steatosis quantification in patients with severe and morbid obesity6
Primary sclerosing cholangitis and cholangiocarcinoma: the 2023 practice guidance and future perspectives6
Screening for pancreatic cancer in individuals with genetic susceptibility6
Radiographic features and behaviors of neuroendocrine tumors: can we judge a book by its cover?6
Alcohol-related liver disease6
Metabolic dysfunction-associated fatty liver disease and hepatocellular carcinoma: present and future6
De-escalating local therapies without compromising outcomes: lessons from the COLLISION trial6
Serum metabolic effects of corn oligopeptides with 7-day supplementation on early post-surgery primary liver cancer patients: a double-blind randomized controlled trial6
Couinaud’s corrosion casts of the liver6
The role of FGFR inhibitors in the treatment of intrahepatic cholangiocarcinoma—unveiling the future challenges in drug therapy5
EREG-secreting THBS1+ tissue monocytes are recruited by C5a to promote rapid liver regeneration in patients and mice during the ALPPS procedure5
Necessity of integrating statistical inference and clinical practice in developing clinical models: bias introduced by neoadjuvant chemotherapy5
Ethical issues in innovative clinical research5
Surgical treatment for neuroendocrine liver metastasis: moving ahead in controversy5
Adjuvant atezolizumab-bevacizumab after curative therapy for hepatocellular carcinoma5
To drain or not to drain after distal pancreatectomy: reflexions on the PANDORINA trial5
Surgical resection for pancreatic ductal adenocarcinoma with liver metastasis: is this the beginning of a new era?5
Feasibility and outcomes of robotic partial pancreatoduodenectomy5
The Hong Kong consensus recommendations on the diagnosis and management of pancreatic cystic lesions5
In situ liver resection under venovenous bypass (LR-VVB) or venoarterial bypass (LR-VAB) adjunct to total vascular exclusion (TVE) as extreme liver surgery5
Advanced pancreatic neuroendocrine neoplasia (pNEN): complex diseases with therapeutic challenges5
Early bifurcation of hepatic artery in right-sided living-donor hepatectomy at Asan Medical Center: rarely a critical issue5
Endothelial glycocalyx damage marker syndecan-1 during hypothermic oxygenated machine perfusion of donor grafts facilitates prediction of early allograft dysfunction after liver transplantation5
Validation of the European Association for the Study of the Liver algorithm for the noninvasive diagnosis of advanced fibrosis in metabolic-dysfunction associated steatotic liver disease5
Nutritional management guidelines for pancreatitis—a commentary5
Utilization of hepatitis B virus-positive allografts in liver transplantation: a new arrow to the bowstring for expanding the donor pool?5
Advancements and challenges in robotic donor hepatectomy: current evidence and unresolved questions5
Risk factors for non-alcoholic fatty liver disease delineate the battlegrounds in optimizing disease prevention5
Getting persuasive about the non-invasive: assessing liver fibrosis in practice—without a biopsy5
Decision-making in high-risk leakage duodenopancreatectomy: pancreatic anastomosis or total pancreatectomy?5
Comparative analysis of analgesic efficacy and functional recovery in open pancreaticoduodenectomy: a randomized controlled trial of local anesthetic wound infiltration, transversus abdominis plane bl5
How to deliver palliative care for patients with management in decompensated cirrhosis5
Can liver stiffness measurement accurately predict disease progression and clinical outcome in patients with metabolic dysfunction-associated steatotic liver disease and bridging fibrosis or cirrhosis5
The upward trend in the immunotherapy utilization for hepatobiliary cancers5
Non-invasive strategies to predict post-hepatectomy liver failure5
The lymphatic vessels of the liver observed by Frederik Ruysch5
Comparative effectiveness of medical treatment vs. metabolic surgery for histologically proven non-alcoholic steatohepatitis and fibrosis: a matched network meta-analysis5
ESMO 2023 pancreatic cancer guidelines signal stepwise progress5
De-escalating surgical treatment in low stage gallbladder cancer5
Risk predictors of post-hepatectomy liver failure: unraveling complexities and navigating challenges in clinical application5
Surgical resection for hepatocellular carcinoma in cirrhotic patients with clinically significant portal hypertension: a multidisciplinary team decision5
Rethinking portal hypertension in hepatocellular carcinoma resection: a gradient of risk beyond black and white5
Hepatic metastases in ovarian cancer4
Standardization is needed in reporting risk and outcomes of machine perfusion in liver transplantation4
Neoadjuvant radiotherapy for resectable hepatocellular carcinoma with portal vein tumor thrombus: a systematic review4
A new TNM T3 subclassification with corresponding prognostic stage grouping for gallbladder cancer: a multicenter retrospective study4
How will the latest modifications to the CG189 NICE guidelines for obesity management likely impact clinical care?4
Hepatic “pregnancy”: hepatocellular carcinoma with extensive extrahepatic growth4
Improving patient stratification and selection for curative-intent treatment in localized pancreatic cancer4
Sex and age differences in the association between obesity and long-term changes with the risk of incident type 2 diabetes mellitus: the Rural Deqing Cohort Study4
Ascites and complications: getting to the root of the trouble4
Liver transplantation for non-resectable colorectal metastases—an evolving paradigm in transplant oncology4
Tailoring bacterial taxa for immune cell modulation4
Exocrine pancreatic insufficiency: more compromise than precision4
Importance of an appropriate number of examined lymph nodes in patients with pancreatic cancer—the more the better?4
Liver venous deprivation (LVD) before extended hepatectomy: a French multicentric retrospective cohort4
A machine learning model for colorectal liver metastasis post-hepatectomy prognostications: several strategies for the model evaluation4
Intestinal autotransplantation: the next level of complexity in locally advanced pancreatic cancer4
Molecular profiling and patient selection for the multimodal approaches for patients with resectable colorectal liver metastases4
The impact of associating liver partition and portal vein ligation for staged hepatectomy (ALPPS) on liver tumors with unusual indications4
Impact of preoperative chemotherapy on surgical results in 139 patients with locally advanced pancreatic cancer3
Short- and long-term outcomes and cost-effectiveness of robotic-assisted versus laparoscopic liver resection for Barcelona Clinic Liver Cancer (BCLC) 0/A hepatocellular carcinoma: a multicenter propen3
A journey of a thousand miles begins with one small step3
Novel biomarkers and the future of targeted therapies in cholangiocarcinoma: a narrative review3
Pancreatic cancer screening in high-risk individuals with genetic susceptibility3
Choledochoscopic photodynamic therapy combined with biliary stent implantation for the treatment of unresectable hilar cholangiocarcinoma3
Is liver resection necessary for T2 gallbladder cancer?3
Modern surgical approach to hepatocellular carcinoma3
Integrative medicine and surgery: what are the diet and supplement recommendations for someone with pancreatic cancer?3
The difficulty of medical decision-making: should patients be involved?3
Lean individuals with nonalcoholic fatty liver disease, the chicken or the egg?3
Atezolizumab plus bevacizumab for patients with Child-Pugh-B in hepatocellular carcinoma3
Insights on liver-directed surgical innovations, targeted therapies, and immunotherapy for biliary tract cancer: navigating the new European Society for Medical Oncology (ESMO) Clinical Practice Guide3
The role of B cells in metabolic (dysfunction)-associated fatty liver disease3
Assessment of morbidity and mortality after liver transplantation for primary sclerosing cholangitis3
New developments in ablation therapy for hepatocellular carcinoma: combination with systemic therapy and radiotherapy3
Roles of the human microbiome in cancer3
Is immunotherapy-related liver injury more common in patients with hepatocellular carcinoma than in other advanced solid tumors?3
Surgical treatment strategies for multifocal hepatocellular carcinomas3
Specific metabolic impairments indicate loss of sustained liver improvements in metabolic dysfunction-associated steatotic liver disease treatment3
Impact of adjuvant therapy on survival outcomes in resected gallbladder cancer: a systematic review and meta-analysis3
An intriguing case of macrolides-induced pancreatic injury mimicking pancreatic carcinoma3
Robotic pancreaticoduodenectomy after the learning curve—a new hope3
Predictive model for very early recurrence of patients with perihilar cholangiocarcinoma: a machine learning approach3
Advanced nonmetastatic hepatocellular carcinoma: curative surgery may be an option3
The global burden of fatty liver disease: the major impact of China3
The vascular endothelial growth factor system—a new player in the pathogenesis and development of metabolic dysfunction- associated steatotic liver disease3
Assessing the financial and equity implications of the 2020 liver allocation policy change3
UDP-glucuronosyltransferases mediate coffee-associated reduction of liver fibrosis in bile duct ligated humanized transgenic UGT1A mice3
Guidelines towards comprehensive care in acute pancreatitis3
Living donor liver transplantation for Barcelona clinic liver cancer (BCLC) intermediate-stage hepatocellular carcinoma3
Alternatives to left lateral segment for pediatric liver transplantation, or required surgeon toolkit?3
Surgical techniques and tumor dissemination: a critical review of the CETUPANC trial on the superior mesenteric artery vs. no-touch approaches3
Beyond chemotherapy in biliary tract cancer: a closer look at the updated long-term follow-up data of the TOPAZ-1 trial3
Obesity and its influence on liver dysfunction, morbidity and mortality after liver resection3
Body mass index and ampulla of Vater cancer incidence and survival: a cohort study of 1.7 million Norwegians2
Hepatectomy guided by the diseased bile duct and hepatic vein for hepatolithiasis2
Comment on: local control and survival after induction chemotherapy and ablative radiation versus resection for pancreatic ductal adenocarcinoma with vascular involvement2
Development and internal validation of the Comprehensive ALPPS Preoperative Risk Assessment (CAPRA) score2
The management strategy of pancreatic cancer in the era of systemic therapy—“Surgery First” or “Surgery Last”?2
Time to say goodbye: from Barcelona to Milan and the modern management of hepatocellular carcinoma2
Commentary on “Effect of green-Mediterranean diet on intrahepatic fat: the DIRECT PLUS randomised controlled trial”2
A European expert consensus surgical technique description for robotic hepatectomy2
ALPPS and the endless pursuit of hepatic resectability2
Advances and controversies in the management of acute cholecystitis in high-risk, critically ill, and unfit-for-surgery patients: the Italian Society of Emergency Surgery and Trauma guidelines2
Babylonian clay tablet of the liver2
Classification of hepatic venous tumor thrombus in hepatocellular carcinoma: should it describe tumor status or predict patient survival?2
Primary Epstein-Barr virus-positive inflammatory follicular dendritic cell sarcoma concurrent with lymphoepithelioma-like intrahepatic cholangiocarcinoma and cavernous hemangioma in liver2
“PUMC’s Three Treasures”: can their glory remain?2
Downstaging and resection of hepatocellular carcinoma in patients with extrahepatic metastases after stereotactic therapy2
Adjuvant therapy for intrahepatic carcinoma after surgical resection: chemotherapy and future perspectives2
In memoriam of Prof. Joseph Wan-yee Lau—our distinguished senior editorial board member2
Long-term results of total pancreatectomy and autologous islet transplantation for chronic pancreatitis: total pancreatectomy with autologous islet transplantation (TPAIT) preserves long-term islet gr2
Anatomical study of the paracaval branch of the caudate lobe: implications of paracaval portion-preserving right hepatectomy for donors with marginal remnant liver volume2
Long-term normothermic machine perfusion of fatty livers: towards transplanting untransplantable livers?2
Epigenome-wide development and validation of a prognostic methylation score in intrahepatic cholangiocarcinoma based on machine learning strategies2
Update on herbal and dietary supplement-induced liver injury: current gaps and future directions2
A review of 2022 Chinese clinical guidelines on the management of hepatocellular carcinoma: updates and insights2
Time-restricted feeding: what we have done and what more we can do?2
Whole grain intake and pancreatic cancer risk2
Predicting early graft loss in pancreas transplantation using novel imaging techniques: are we there yet?2
Evolving concepts in the management of hepatocellular carcinoma: from ‘stage hierarchy’ to the ‘multiparametric therapeutic hierarchy’ approach2
Quest for an accurate and reproducible prognostic biomarker of severe acute pancreatitis: have we finally found it?2
Liver resection in obesity patients2
Positive pancreatic neck margins—a telltale sign of complex biology2
Patient with unresectable colorectal liver metastases and asymptomatic primary tumor: end of the debate!2
High risk of thrombosis recurrence in people with idiopathic or only locally caused non-cirrhotic splanchnic vein thrombosis: it is time for guidelines’ revision2
Giant accessory hepatic lobe accompanied by inflammatory pseudotumor2
Challenges and innovations in adjuvant therapy for gallbladder cancer: a meta-analytic perspective2
Anatomical complexity of the right-lobe grafts: influence on the outcomes in living donor liver transplantation2
Nonalcoholic fatty liver disease in early life and all-cause and cause-specific mortality2
Liver transplantation for colorectal liver metastasis: the exception, not the rule2
Effects of exercise and nutrition in improving sarcopenia in liver cirrhosis patients: a systematic review and meta-analysis2
Primary tumor location and KRAS mutation: key prognostic factors in surgically treated colorectal liver metastases2
Alternatives to left lateral sector in paediatric liver transplantation—a systematic review on monosegmental and reduced grafts2
β-cryptoxanthin and fatty liver disease: new insights2
Is FOLFOX-HAIC superior to transarterial chemoembolization in treating large hepatocellular carcinoma?2
A novel nomogram for predicting the prognosis of hepatocellular carcinoma patients following immune checkpoint inhibitors treatment beyond progression: a single center study based on Chinese populatio2
Continuous normothermic machine perfusion of donor livers in the United States: the challenging road from the trial-world into the real-world2
Providing meaningful survival benefit to hepatocellular carcinoma patients: combination therapy of future2
Genomic alterations in hepatocellular carcinoma and their clinical application to genomic medicine2
Liver anatomy by Francis Glisson2
Short- and long-term outcomes of laparoscopic versus open resection of perihilar cholangiocarcinoma: a propensity score-based analysis2
Utility of liver resection for breast cancer liver metastases, time for action2
Minimally invasive liver resection for huge (≥10 cm) tumors: an international multicenter matched cohort study with regression discontinuity analyses2
Long- and short-term outcomes for resectable gallbladder carcinoma patients treated with curative-intent laparoscopic versus open resection: a multicenter propensity score-matched comparative study2
Using the win ratio to compare laparoscopic versus open liver resection for colorectal cancer liver metastases2
Robotic-assisted cholecystectomy: stepping stone to expertise or vogue?2
The risk of hepatocellular carcinoma recurrence after liver transplantation increases with locoregional therapies in patients initially within Milan criteria2
Segment 8 hepatic vein reconstruction in a living donor after left hepatectomy2
Regional differences: clinical practice guidelines on the management of hepatocellular carcinoma2
A novel non-invasive model to predict high-risk varices in cirrhotic patients2
A combined pre- and intra-operative nomogram in evaluation of degrees of liver cirrhosis predicts post-hepatectomy liver failure: a multicenter prospective study2
Advances in minimally invasive liver surgery: comparing robotic and laparoscopic approaches2
Foregut bypass vs. restrictive bariatric procedures for nonalcoholic fatty liver disease: a meta-analysis of 3,355 individuals2
Pancreatic carcinoma disguised as type 1 autoimmune pancreatitis with a mass-forming appearance: a clinical dilemma2
The role of MRI in modifying surgical management of colorectal liver metastases: a lesson from the CAMINO trial2
0.095812082290649